Himpebzi subcutaneous injection 150 mg pen, manufactured by Pfizer, contains Marstacimab (genetical recombination) and is a subcutaneous injectable drug supplied as a 150 mg x 1 mL kit (YJ code: 6343462G1026). It is used for routine prophylaxis to prevent or reduce bleeding episodes in adult and pediatric patients with hemophilia A or B.
Himpebzi subcutaneous injection 150 mg pen
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).